For research use only. We do not sell to patients.
Linsitinib-d3
CAS No. : 1304632-17-4
Biological Activity：Linsitinib-d3 (OSI-906-d3) is the deuterium labeled Linsitinib. Linsitinib (OSI-906) is a potent, selective and orally bioavailable dual inhibitor of the IGF-1 receptor and insulin receptor (IR) with IC50s of 35 and 75 nM, respectively.
Research Area：Cancer|Endocrinology
Targets：Insulin Receptor|IGF-1R
Related Small Molecules:AGL-2263;AZ7550 Mesylate;KU14R;Picropodophyllotoxin-d6;SU4984;Chromeceptin;I-OMe-Tyrphostin AG 538;Ganitumab;HNMPA-(AM)3;S961 TFA;OI338;Gastric Inhibitory Peptide, porcine;MSDC 0160;[Tyr0] Gastric Inhibitory Peptide (23-42), human;AVJ16;GIP, human;GSK1838705A;DA-JC4;MSDC-0602K;AG1024;Xentuzumab;Teprotumumab;IGF-I (24-41)
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
